在宫癌查中基因型特异性高风险人乳头瘤病毒检测的重要性:一项基于医院的研究
Sarocha Boonkate1, Wathirada Karnchanabanyong1, Irene Ruengkhachorn1
1Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Journal of medical virology
|August 14, 2025
概括
高危人乳头瘤病毒 (hrHPV) 基因定型确定HPV16是2级或更严重 (CIN2+) 宫内皮质瘤的关键预测因子. 多种多样性也增加了风险,改进了对 hrHPV 阳性女性的查策略.
科学领域:
- 妇科瘤学 妇科瘤学
- 病毒学 病毒学
- 病理学 病理学 病理学
背景情况:
- 宫癌查依赖于检测高风险的人类乳头瘤病毒 (hrHPV) 感染.
- 扩展的HPV基因型鉴定可能会比标准的hrHPV检测更好地提高风险分层.
- 了解2级或更严重的宫内皮质瘤 (CIN2+) 的预测因子对于及时干预至关重要.
研究的目的:
- 探索 hrHPV 阳性女性的组织病理结果.
- 评估扩展HPV基因型鉴定在风险评估中的意义.
- 在 hrHPV 阳性女性中确定 CIN2+ 的预测因子.
主要方法:
- 对1981年为hrHPV (2020-2023) 呈阳性查的妇女的医疗记录的回顾性审查.
- 收集HPV基因型测定结果,诊断程序和组织病理学发现.
- 使用SPSS进行统计分析,显著性设置为p < 0.05;计算了几率比率 (OR) 和95%信心区间 (CI).
主要成果:
- 在7.7% (152/1981) 的 hrHPV阳性女性中检测到CIN2+.
- 检测到HPV16显著增加了CIN2+风险 (OR为4.534,95%CI为3.1976.430).
- 多样性也是CIN2+ (OR1.497,95%CI:1.0702.094) 的一个重要预测因素.
结论:
- 扩展的hrHPV基因型鉴定,特别是识别HPV16,完善了CIN2+的风险分层.
- HPV16 和多对性是 hrHPV 阳性女性中 CIN2+ 病变的显著预测因素.
- 这些发现支持针对特定患者群体加强监测和管理策略.
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509


